Breaking News

Herbalife Expects to Beat Q4 Estimates

February 3, 2014

Will boost share buybacks, too.

Herbalife expects fourth-quarter sales to rise 19.8% to about $1.27 billion, just ahead of the consensus estimate of $1.22 billion. Adjusted diluted earnings per share (EPS) is now guided to a range of $1.26 to $1.30, versus a consensus estimate of $1.17.

For the full fiscal year, Herbalife expects revenues will rise 18.5% to about $4.82 billion, also ahead of a consensus estimate of $4.78 billion.

The company also increased its share repurchase authorization to $1.5 billion, up from a previous authorization of $1 billion, of which $653 million was still available.

 

Related End-User Markets:

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • Organic Matter

    Organic Matter

    Christine Esposito, Associate Editor||November 14, 2016
    FTC and USDA hold a public roundtable to discuss consumers’ perception of organic claims.

  • Get Ready, ‘Cause Here it Comes…

    Get Ready, ‘Cause Here it Comes…

    Christine Esposito, Associate Editor||November 1, 2016
    Skinphonic is a new brand created with a team of beauty experts and fronted by singer Smokey Robinson.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • Perform or Perish

    Perform or Perish

    Christine Esposito, Associate Editor||December 1, 2016
    Success in today’s skin care sector begins with active ingredients, formulated in products that address modern-day issues.

  • Soap Opera

    Soap Opera

    Christine Esposito, Associate Editor||November 2, 2016
    FDA’s recent antibacterial ruling has soap sector stakeholders scrambling to keep some ingredients in their formulation kit.